Fig. 5From: Biodistribution and post-therapy dosimetric analysis of [177Lu]Lu-DOTAZOL in patients with osteoblastic metastases: first resultsComparison of organ absorbed doses of [177Lu]Lu-DOTAZOL with [177Lu]Lu-EDTMP [5, 26], [177Lu]Lu-PSMA-617 [33, 36].Back to article page